Opioid versus opioid-free analgesia after surgical discharge: protocol for a systematic review and meta-analysis. Issue 1 (2nd February 2020)

• Record Type: Journal Article
• Authors: El-Kefraoui, Charbel; Olleik, Ghadeer; Chay, Marc-Aurele; Kouyoumdjian, Araz; Nguyen-Powanda, Philip; Rajabiyazdi, Fateme; Do, Uyen; Derksen, Alexa; Landry, Tara; Amar-Zifkin, Alexandre; Ramanakumar, Agnihotram V.; Martel, Marc-Olivier; Baldini, Gabriele; Feldman, Liane; Fiore Jr, Julio F
• Is Part Of: BMJ open. Volume 10:Issue 1(2020)
• Publication Date: 2020-02-02
• Subjects: surgery -- pain management -- adult surgery; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2019-035443
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Excessive prescribing after surgery has contributed to a public health crisis of opioid addiction and overdose in North America. However, the value of prescribing opioids to manage postoperative pain after surgical discharge remains unclear. We propose a systematic review and meta-analysis to assess the extent to which opioid analgesia impact postoperative pain intensity and adverse events in comparison to opioid-free analgesia in patients discharged after surgery. Methods and analysis: Major electronic databases (MEDLINE, Embase, Cochrane Library, Scopus, AMED, BIOSIS, CINAHL and PsycINFO) will be searched for multi-dose randomised-trials examining the comparative effectiveness of opioid versus opioid-free analgesia after surgical discharge. Studies published from January 1990 to July 2019 will be targeted, with no language restrictions. The search will be re-run before manuscript submission to include most recent literature. We will consider studies involving patients undergoing minor and major surgery. Teams of reviewers will, independently and in duplicate, assess eligibility, extract data and evaluate risk of bias. Our main outcomes of interest are pain intensity and postoperative vomiting. Study results will be pooled using random effects models. When trials report outcomes for a common domain (eg, pain intensity) using different scales, we will convert effect sizes to a common standard metric (eg, Visual Analogue Scale). Minimally important clinical differences reported in previous literature will be considered when interpreting results. Subgroup analyses defined a priori will be conducted to explore heterogeneity. Risk of bias will be assessed according to the Cochrane Collaboration's Risk of Bias Tool 2.0. The quality of evidence for all outcomes will be evaluated using the GRADE rating system. Ethics and dissemination: Ethical approval is not required since this is a systematic review of published studies. Our results will be published in a peer-reviewed journal and presented at relevant conferences. Further knowledge dissemination will be sought via public and patient organisations focussed on pain and opioid-related harms.